Company Filing History:
Years Active: 2023
Title: Jurriën Prins: Innovator in Polyomavirus Research
Introduction
Jurriën Prins is a notable inventor based in The Hague, Netherlands. He has made significant contributions to the field of virology, particularly in the study of polyomavirus replication. His innovative work has led to the development of a patent that addresses critical aspects of viral replication.
Latest Patents
Jurriën Prins holds a patent titled "Inhibition of polyomavirus replication." This invention relates to antisense molecules and methods for modulating the splicing of polyomavirus T antigen pre-mRNA. The patent describes an antisense oligonucleotide that is 12 to 30 nucleobases in length, preferably between 17 and 20 nucleobases. This oligonucleotide comprises a sequence that is the reverse complement of a contiguous stretch of at least 12 nucleobases of polyomavirus T-antigen pre-mRNA. The invention aims to modulate the splicing of T-antigen pre-mRNA in a cell, providing a potential therapeutic approach to combat polyomavirus infections.
Career Highlights
Jurriën Prins is affiliated with Academisch Ziekenhuis Leiden, also known as LUMC. His work at this esteemed institution has allowed him to collaborate with leading researchers in the field. His dedication to advancing scientific knowledge has positioned him as a key figure in virology research.
Collaborations
Throughout his career, Jurriën Prins has worked alongside esteemed colleagues such as Eric Peter Van Der Veer and Anton Jan Van Zonneveld. These collaborations have fostered a rich environment for innovation and discovery in the realm of polyomavirus research.
Conclusion
Jurriën Prins is a distinguished inventor whose work in the inhibition of polyomavirus replication has the potential to impact therapeutic strategies significantly. His contributions to the field of virology exemplify the importance of innovation in addressing complex medical challenges.